Astaxanthin long-acting nano preparation prepared through micelle template method and preparation method for astaxanthin long-acting nano preparation

A nano-formulation, astaxanthin technology, applied in the directions of antitoxin, capsule delivery, micro-capsules, etc., can solve the problem of less research on the hepatoprotective effect of astaxanthin and its preparations, and achieve excellent liver protection effect and dispersion. Good property and the effect of improving solubility

Active Publication Date: 2021-08-13
JIANGSU UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, there are few reports on astaxanthin long-acting preparations, and there are few studies on the hepatoprotective effect of astaxanthin and its preparations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Astaxanthin long-acting nano preparation prepared through micelle template method and preparation method for astaxanthin long-acting nano preparation
  • Astaxanthin long-acting nano preparation prepared through micelle template method and preparation method for astaxanthin long-acting nano preparation
  • Astaxanthin long-acting nano preparation prepared through micelle template method and preparation method for astaxanthin long-acting nano preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The preparation of embodiment 1 astaxanthin nano-preparation

[0034] (1) Accurately weigh 5mg of astaxanthin and dissolve it in 0.5mL of dichloromethane, and make it homogeneous by ultrasonication for 10min. Accurately weigh 15 mg of phospholipids and 10 mg of sodium cholate and dissolve them in a mixed solvent of 0.5 mL of methanol, and ultrasonicate for 10 min to make them uniform. Accurately weigh 50 mg of PLGA and dissolve it in 2 mL of dichloromethane, and ultrasonicate for 10 min to make it uniform. Disperse the astaxanthin solution into the mixed solution of phospholipid and sodium cholate, and disperse it fully by ultrasonication for 10 minutes, then disperse this solution in the PLGA solution, and disperse it fully by ultrasonication for 10 minutes to obtain an organic phase with a total volume of 3 mL. Disperse the organic phase in 6 mL of 4% PVA403 aqueous solution to emulsify it, then disperse the emulsion in 10 mL of 0.5% PVA 403 aqueous solution, stir ov...

Embodiment 2

[0036] The preparation of embodiment 2 astaxanthin nano-preparations

[0037] (1) Accurately weigh 5 mg of astaxanthin and dissolve it in 2 mL of dichloromethane, and ultrasonicate for 10 min to make it uniform. Accurately weigh 35 mg of phospholipids and 25 mg of sodium cholate and dissolve them in a mixed solvent of 1 mL of dichloromethane and 3 mL of methanol, and ultrasonicate for 10 min to make them uniform. Accurately weigh 250 mg of PLGA and dissolve it in 4 mL of dichloromethane, and ultrasonicate for 10 min to make it uniform. Disperse the astaxanthin solution into the mixed solution of phospholipid and sodium cholate, and disperse it fully by ultrasonication for 10 minutes, then disperse this solution in the PLGA solution, and disperse it fully by ultrasonication for 10 minutes to obtain an organic phase with a total volume of 10 mL. Disperse the organic phase in 15 mL of 4% PVA403 aqueous solution to emulsify it, then disperse the emulsion in 50 mL of 1% PVA 403 aq...

Embodiment 3

[0039] The preparation of embodiment 3 astaxanthin nano-preparations

[0040] (1) Accurately weigh 10 mg of astaxanthin and dissolve it in 2 mL of dichloromethane, and ultrasonicate for 10 min to make it uniform. Accurately weigh 70 mg of phospholipids and 50 mg of sodium cholate and dissolve in a mixed solvent of 1 mL of dichloromethane and 3 mL of methanol, and ultrasonicate for 10 min to make them uniform. Accurately weigh 400mg of PLGA and dissolve it in 4mL of dichloromethane, and ultrasonicate for 10min to make it uniform. Disperse the astaxanthin solution into the mixed solution of phospholipid and sodium cholate, and disperse it fully by ultrasonication for 10 minutes, then disperse this solution in the PLGA solution, and disperse it fully by ultrasonication for 10 minutes to obtain an organic phase with a total volume of 10 mL. Disperse the organic phase in 15 mL of 4% PVA 403 aqueous solution to emulsify it, then disperse the emulsion in 40 mL of 1% PVA 403 aqueous ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses an astaxanthin long-acting nano preparation prepared through a micelle template method and a preparation method for the astaxanthin long-acting nano preparation, and relates to the field of nano pharmaceutical preparations. Phospholipid and sodium cholate are used as micelle templates, and a solubilizing and synergy carrier is provided for insoluble compound astaxanthin; the novel astaxanthin micelle-loaded PLGA nano preparation is prepared from astaxanthin, phospholipid, sodium cholate and PLGA in a mass ratio of 1: (3-7): (2-5): (10-50) through an emulsion solvent evaporation method by taking a polylactic acid-glycolic acid copolymer as a long-acting carrier, wherein the ratio of a total organic phase to a total water phase is 1: (5-25). According to the preparation, on the premise that the solubility of the astaxanthin is remarkably improved, the long-acting liver protection effect of the astaxanthin is achieved at the same time. The process is simple, the micelle template is innovatively applied to preparation of the insoluble medicine long-acting preparation, and has a good application prospect.

Description

technical field [0001] The invention relates to the field of nano-pharmaceutical preparations, in particular to a long-acting nano-preparation of insoluble active ingredient astaxanthin and a preparation method thereof. Background technique [0002] Astaxanthin, 3,3'-dihydroxy-4,4'-diketo-β,β'-carotene, is a ketone-type non-vitamin A source carotenoid, which is a reddish-brown terpene ethylenically unsaturated compounds. As a chain-breaking antioxidant, astaxanthin can not only quench singlet oxygen, directly scavenge oxygen free radicals, but also block the chain reaction of fatty acids, and has strong antioxidant activity (see: Zuluaga, M. , V. Gueguen, D. Letourneur, et al., Astaxanthin-antioxidant impact on excessive Reactive Oxygen Species generation induced byischemia and reperfusion injury [J]. Chemico-Biological Interactions, 2018.279:145-158). Astaxanthin is a natural pigment carotenoid approved by the US Food and Drug Administration (FDA) with various biological ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/51A61K9/107A61K31/122A61K47/24A61K47/28A61K47/34A61P1/16A61P39/06
CPCA61K9/5153A61K9/5192A61K9/1075A61K31/122A61K47/24A61K47/28A61P1/16A61P39/06
Inventor 朱源廖有武李双顾正清薛媛媛彭后平
Owner JIANGSU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products